126 related articles for article (PubMed ID: 2561734)
1. Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-beta 1.
Fan D; Chakrabarty S; Seid C; Bell CW; Schackert H; Morikawa K; Fidler IJ
Cancer Commun; 1989; 1(2):117-25. PubMed ID: 2561734
[TBL] [Abstract][Full Text] [Related]
2. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2.
Chakrabarty S; Fan D; Varani J
Int J Cancer; 1990 Sep; 46(3):493-9. PubMed ID: 1697568
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro.
Gomella LG; Sargent ER; Linehan WM; Kasid A
J Urol; 1989 May; 141(5):1240-4. PubMed ID: 2540353
[TBL] [Abstract][Full Text] [Related]
4. Biological effects and binding properties of transforming growth factor-beta on human oral squamous cell carcinoma cells.
Ichijo H; Momose F; Miyazono K
Exp Cell Res; 1990 Apr; 187(2):263-9. PubMed ID: 2156718
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.
Hoosein NM; McKnight MK; Levine AE; Mulder KM; Childress KE; Brattain DE; Brattain MG
Exp Cell Res; 1989 Apr; 181(2):442-53. PubMed ID: 2538337
[TBL] [Abstract][Full Text] [Related]
7. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
[TBL] [Abstract][Full Text] [Related]
8. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
10. Evidence for metastatic heterogeneity of human renal cell carcinoma.
Naito S; Walker SM; von Eschenbach AC; Fidler IJ
Anticancer Res; 1988; 8(6):1163-7. PubMed ID: 3218952
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
12. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors.
Game SM; Stone A; Scully C; Prime SS
Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor beta is dependent on the presence of polyunsaturated fatty acids.
Newman MJ
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5543-7. PubMed ID: 2371287
[TBL] [Abstract][Full Text] [Related]
14. Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines.
Murthy U; Anzano MA; Greig RG
Int J Cancer; 1989 Jul; 44(1):110-5. PubMed ID: 2545633
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
Wu SP; Theodorescu D; Kerbel RS; Willson JK; Mulder KM; Humphrey LE; Brattain MG
J Cell Biol; 1992 Jan; 116(1):187-96. PubMed ID: 1730743
[TBL] [Abstract][Full Text] [Related]
17. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
Hsu S; Huang F; Hafez M; Winawer S; Friedman E
Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
[TBL] [Abstract][Full Text] [Related]
18. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.
Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E
Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL
Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
